Journal of family medicine and primary care · 2022
Telmisartan-induced angioedema: A rare clinical finding.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kumar Nitesh, Kiran Madhu, Gupta Kapil, Pareek Shatrughan
Аннотация
Angioedema is swelling that mostly involves the soft tissue of the eyelids, nose, throat, tongue, mouth, or genitals. Angiotensin converting enzyme inhibitors induced angioedema is a rare but potentially dangerous adverse effect. A 52-year-old female patient attended the emergency department with the history swelling over the eyes and face past 3 days and having difficulty in swallowing of the food. Her medical history revealed that the patient was recently diagnosed with hypertension and was on the combination of Telmisartan and Amlodipin (40 mg + 5 mg). The medicines were immediately stopped and the patient was managed symptomatically for angioedema. The symptoms declined after 5 days of discontinuity of medicines. The case report can be considered as rare adverse effects of the Telmisartan. Angiotensin receptor blockers induced angioedema is a rare presentation.